12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

OctoPlus deal

OctoPlus will develop a controlled-release formulation of an undisclosed peptide...

Read the full 30 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >